Edward G Griffin - World Without Cancer; The Story of Vitamin B17

Third edition: August 2011

Second edition: January 1997

First edition: December 1974

Second Russian edition: February 2017

Serbian edition: 2013 March

Russian edition: 2011 October

Czech edition: 2011 July

Croatian edition: 2011 July

Norwegian edition: 2006 October

German edition: 2005 November

Hungarian edition: 2005 July

Japanese edition: 1978 March

Copyright 2011, 1997, and 1974 by G. Edward Griffin

All rights reserved

Kindle Edition published by Dauphin Publications

www.DauPub.com

Library of Congress Catalog Card Number: 96-84094

Table of Contents

DEDICATION

This book is dedicated to the memory of Dr. Ernst T. Krebs, Jr., and John A. Richardson, M.D. When confronted by the power and malice of entrenched scientific error, they did not flinch. While others scampered for protective shelter, they moved to the front line of battle. May the telling of their deeds help to arouse an indignant public which, alone, can break the continuing hold of their enemies over our lives and our health.

A NOTE OF APPRECIATION

AND GRATITUDE

The material in this volume could not have been assembled without the help and guidance of many others. I am indebted to the late Dr. John Richardson for his persistent hammering away on the significance of vitamin therapy until it finally began to penetrate into this thick skull; and to my wife, Patricia, who, for several months prior, had attempted to arouse my curiosity on the subject. I will always be indebted to the late Dr. Ernst T. Krebs, Jr., for his patience and thoroughness in explaining and re-explaining so many scientific matters. I am grateful to Bruce Buchbinder, Ralph Bowman, Malvina Cassese, Frank Cortese, George Ham, Grace Hamilton, Jim Foley, Mac and Idell Hays, Pokie Korsgaard, Sanford Kraemer, Dr. J. Milton Hoffman, Maurice LeCover, Bob Lee, Betty Lee Morales, Beverly Newkirk, John Pursely, Julie Richardson, Bob Riddel, Lorraine Rosenthal, Alice Tucker, Lloyd Wallace, M.P. Wehling, Kimo Welch, Melinda Wiman, Ann Yalian, and others too numerous to mention for their strong encouragement, endless patience, and tangible support.

FOREWORD

A great deal of drama has been enacted on the cancer stage since the first edition of this book was published. While it is true that many of the original actors have been replaced by their understudies, the plot of the play has not changed. This is the outline of that drama.

Each year, thousands of Americans travel to Mexico and Germany to receive Laetrile therapy. They do this because it has been suppressed in the United States. Most of these patients have been told that their cancer is terminal and they have but a few months to live. Yet, an incredible percentage of them have recovered and are living normal lives. However, the FDA, the AMA, the American Cancer Society, and the cancer research centers continue to pronounce that Laetrile is quackery. The recovered patients, they say, either had "spontaneous remissions" or never had cancer in the first place.

If any of these people ultimately die after seeking Laetrile, spokesmen for orthodox medicine are quick to proclaim: "You see? Laetrile doesn't work!" Meanwhile, hundreds of thousands of patients die each year after undergoing surgery, radiation, or chemotherapy, but those treatments continue to be touted as "safe and effective."

The average cancer patient undergoing Laetrile therapy will spend between $5,000 and $25,000 for treatment. That is a lot of money, but it is peanuts compared to the astronomical bills charged by conventional medicine. Yet they never tire of complaining that Laetrile doctors are greedy quacks and charlatans who profiteer from the sick and the frightened.

That is a classic case of accusing your opponent of exactly what you yourself are doing. It is common today for an elderly couple to give their entire life savings to a medical center and a battery of attending physicians and technicians, all in the vain hope of saving the husband or wife from cancer. Even their house may have to be sold to pay the bills. And the maddening part is that, in most cases, the doctors know there is no chance of long-term success. But the surviving spouse is seldom told that.

The next time you hear a spokesman for orthodox medicine condemn those greedy, money-grubbing Laetrile doctors, watch him as he goes to the parking lot. Chances are, he'll drive off in his new Jaguar.

The only real difference between the controversy today and when it began in the 1970s is that the media has lost interest in it. The sparsity of coverage has created the false impression that. Laetrile has fallen into disfavor, but nothing could be further from the truth. The number of patients using Laetrile today continues to run in the thousands.

It has been suggested that the mass media have decided to ignore Laetrile because, when it did receive national publicity, it became popular. People decided to give it a try in spite of the negative press. If they had been told they were going to die anyway, why not? And the clinics in Mexico thrived. Another reason may be that, although the controversy continues, there is nothing of substance that is really new. Each unfolding event is merely an extension of forces and arguments that have preceded.

For example, in 1977, the parents of Chad Green kidnapped their own son and took him to Mexico to avoid being forced by officials in Massachusetts into giving him chemotherapy for his leukemia. They preferred nutritional therapy instead. This is part of the heavy price we pay for allowing government the power to decide what is best for us and our families. When special-interest groups become politically strong enough to write the laws, then it is those groups that tell us what to doall in the name of protecting us, of course.

The Chad Green story made big headlines but, unfortunately, the same thing involving other children has happened numerous times since then with only minor news coverage. For example, in 1999, James and Donna Navarro were told that their four-year-old son, Thomas, had a malignant brain tumor. Surgery left the child speechless, blind, and unable to walk. When the doctors told the Navarros that Thomas would also have to undergo radiation and chemotherapy, they researched the medical literature and learned that these treatments probably would further impair the boys brain function and that long-term survival was unlikely anyway. So they decided to try an alternative therapy called antineoplastons offered at the Stanislaw R. Burzynsky Research Institute in Houston. At this point, the FDA stepped in and prohibited Dr. Burzynsky from accepting the boy as a patient unless he first had undergone chemotherapy and radiation.

Mr. Navarro explains: "What they don't understand is that there won't be anything left of him to salvage if we make him take that awful treatment first." When he did not fall in line with the doctors' demands, he began to receive harassing phone calls from hospital personnel. One oncologist threatened to file charges with the state. When Mr. Navarro still refused, the doctor went to the protective-services agency and filed child abuse charges against the parents.

In 1980, movie actor Steve McQueen also made news when he went to Mexico for Laetrile and other unorthodox therapies. When he died following surgery four months later, the press had a heyday telling the American people that Laetrile didn't work. What they failed to report is that McQueen's cancer was, indeed, apparently cured by Laetrile, and that only a non-cancerous tumor remained in his abdomen. (Most tumors are composed of a mixture of cancer and non-cancerous tissue.) McQueen was feeling great and decided to have the bulge removed for cosmetic reasons. It was a complication of that surgery, not cancer, which caused his death. Not a word of his prior recovery was to be found in the major press. Consequently, millions of Americans who followed the story came away with the conviction that Laetrile is just another hoax. That, too, is merely an extension of the kind of biased media reporting that has become a permanent part of the coverage of Laetrile. It continues today.